The impact of left ventricle assist device on circulating endothelial microparticles - Pilot study

Jan Pitha, Zora Dorazilova, Vojtech Melenovsky, Ivana Kralova Lesna, Petr Stavek, Jitka Stepankova, Marian Urban, Jiri Maly, Ivan Netuka

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

OBJECTIVES: Recent technological breakthroughs in the design of reliable systems for long term non-pulsatile mechanical heart support offer the possibility to study the effect of continuous blood flow in the vascular system. Generally, it is assumed that the absence of physiological pulsatile flow leads to prothrombogenic and proatherogenic changes. We investigated the change in the circulating endothelial microparticle concentration as a marker of endothelial damage in patients implanted with a continuous-flow left ventricle assist device (LVAD). METHODS: Endothelial microparticles were measured in 8 males (mean age 54.1±11.5 years) with terminal heart failure before and 3 months after implantation of an LVAD. The group consisted of 3 patients with dilated cardiomyopathy, 3 patients with ischemic cardiomyopathy, 1 patient with both conditions and 1 patient with congenital valvular disease. The concentration of endothelial microparticles was determined by ELISA Zymutest MP activity test. RESULTS: We did not observe a significant change in the concentration of circulating endothelial microparticles measured before and 3 months after implantation (p=0.669). High inter-individual variability in response to implantation was found. However, no association between a change in endothelial microparticle concentration and heart failure aetiology or a significant clinical complication attributed to LVAD implantation was observed. CONCLUSION: Results from this preliminary pilot study do not indicate that LVADs contribute to short-term vascular damage as defined by an increase in circulating endothelial microparticles.

Original languageEnglish (US)
Pages (from-to)68-72
Number of pages5
JournalNeuroendocrinology Letters
Volume33
Issue numberSUPPL. 2
StatePublished - Dec 19 2012

Fingerprint

Heart-Assist Devices
Heart Ventricles
Blood Vessels
Heart Failure
Pulsatile Flow
Dilated Cardiomyopathy
Cardiomyopathies
Enzyme-Linked Immunosorbent Assay

Keywords

  • Circulating endothelial microparticles
  • Endothelial dysfunction
  • Heart failure
  • Non-pulsatile flow
  • Ventricle assist device

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Neurology
  • Endocrine and Autonomic Systems
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Pitha, J., Dorazilova, Z., Melenovsky, V., Kralova Lesna, I., Stavek, P., Stepankova, J., ... Netuka, I. (2012). The impact of left ventricle assist device on circulating endothelial microparticles - Pilot study. Neuroendocrinology Letters, 33(SUPPL. 2), 68-72.

The impact of left ventricle assist device on circulating endothelial microparticles - Pilot study. / Pitha, Jan; Dorazilova, Zora; Melenovsky, Vojtech; Kralova Lesna, Ivana; Stavek, Petr; Stepankova, Jitka; Urban, Marian; Maly, Jiri; Netuka, Ivan.

In: Neuroendocrinology Letters, Vol. 33, No. SUPPL. 2, 19.12.2012, p. 68-72.

Research output: Contribution to journalArticle

Pitha, J, Dorazilova, Z, Melenovsky, V, Kralova Lesna, I, Stavek, P, Stepankova, J, Urban, M, Maly, J & Netuka, I 2012, 'The impact of left ventricle assist device on circulating endothelial microparticles - Pilot study', Neuroendocrinology Letters, vol. 33, no. SUPPL. 2, pp. 68-72.
Pitha J, Dorazilova Z, Melenovsky V, Kralova Lesna I, Stavek P, Stepankova J et al. The impact of left ventricle assist device on circulating endothelial microparticles - Pilot study. Neuroendocrinology Letters. 2012 Dec 19;33(SUPPL. 2):68-72.
Pitha, Jan ; Dorazilova, Zora ; Melenovsky, Vojtech ; Kralova Lesna, Ivana ; Stavek, Petr ; Stepankova, Jitka ; Urban, Marian ; Maly, Jiri ; Netuka, Ivan. / The impact of left ventricle assist device on circulating endothelial microparticles - Pilot study. In: Neuroendocrinology Letters. 2012 ; Vol. 33, No. SUPPL. 2. pp. 68-72.
@article{270a9c166916438c9831192491925e25,
title = "The impact of left ventricle assist device on circulating endothelial microparticles - Pilot study",
abstract = "OBJECTIVES: Recent technological breakthroughs in the design of reliable systems for long term non-pulsatile mechanical heart support offer the possibility to study the effect of continuous blood flow in the vascular system. Generally, it is assumed that the absence of physiological pulsatile flow leads to prothrombogenic and proatherogenic changes. We investigated the change in the circulating endothelial microparticle concentration as a marker of endothelial damage in patients implanted with a continuous-flow left ventricle assist device (LVAD). METHODS: Endothelial microparticles were measured in 8 males (mean age 54.1±11.5 years) with terminal heart failure before and 3 months after implantation of an LVAD. The group consisted of 3 patients with dilated cardiomyopathy, 3 patients with ischemic cardiomyopathy, 1 patient with both conditions and 1 patient with congenital valvular disease. The concentration of endothelial microparticles was determined by ELISA Zymutest MP activity test. RESULTS: We did not observe a significant change in the concentration of circulating endothelial microparticles measured before and 3 months after implantation (p=0.669). High inter-individual variability in response to implantation was found. However, no association between a change in endothelial microparticle concentration and heart failure aetiology or a significant clinical complication attributed to LVAD implantation was observed. CONCLUSION: Results from this preliminary pilot study do not indicate that LVADs contribute to short-term vascular damage as defined by an increase in circulating endothelial microparticles.",
keywords = "Circulating endothelial microparticles, Endothelial dysfunction, Heart failure, Non-pulsatile flow, Ventricle assist device",
author = "Jan Pitha and Zora Dorazilova and Vojtech Melenovsky and {Kralova Lesna}, Ivana and Petr Stavek and Jitka Stepankova and Marian Urban and Jiri Maly and Ivan Netuka",
year = "2012",
month = "12",
day = "19",
language = "English (US)",
volume = "33",
pages = "68--72",
journal = "Neuroendocrinology Letters",
issn = "0172-780X",
publisher = "Maghira and Maas Publications",
number = "SUPPL. 2",

}

TY - JOUR

T1 - The impact of left ventricle assist device on circulating endothelial microparticles - Pilot study

AU - Pitha, Jan

AU - Dorazilova, Zora

AU - Melenovsky, Vojtech

AU - Kralova Lesna, Ivana

AU - Stavek, Petr

AU - Stepankova, Jitka

AU - Urban, Marian

AU - Maly, Jiri

AU - Netuka, Ivan

PY - 2012/12/19

Y1 - 2012/12/19

N2 - OBJECTIVES: Recent technological breakthroughs in the design of reliable systems for long term non-pulsatile mechanical heart support offer the possibility to study the effect of continuous blood flow in the vascular system. Generally, it is assumed that the absence of physiological pulsatile flow leads to prothrombogenic and proatherogenic changes. We investigated the change in the circulating endothelial microparticle concentration as a marker of endothelial damage in patients implanted with a continuous-flow left ventricle assist device (LVAD). METHODS: Endothelial microparticles were measured in 8 males (mean age 54.1±11.5 years) with terminal heart failure before and 3 months after implantation of an LVAD. The group consisted of 3 patients with dilated cardiomyopathy, 3 patients with ischemic cardiomyopathy, 1 patient with both conditions and 1 patient with congenital valvular disease. The concentration of endothelial microparticles was determined by ELISA Zymutest MP activity test. RESULTS: We did not observe a significant change in the concentration of circulating endothelial microparticles measured before and 3 months after implantation (p=0.669). High inter-individual variability in response to implantation was found. However, no association between a change in endothelial microparticle concentration and heart failure aetiology or a significant clinical complication attributed to LVAD implantation was observed. CONCLUSION: Results from this preliminary pilot study do not indicate that LVADs contribute to short-term vascular damage as defined by an increase in circulating endothelial microparticles.

AB - OBJECTIVES: Recent technological breakthroughs in the design of reliable systems for long term non-pulsatile mechanical heart support offer the possibility to study the effect of continuous blood flow in the vascular system. Generally, it is assumed that the absence of physiological pulsatile flow leads to prothrombogenic and proatherogenic changes. We investigated the change in the circulating endothelial microparticle concentration as a marker of endothelial damage in patients implanted with a continuous-flow left ventricle assist device (LVAD). METHODS: Endothelial microparticles were measured in 8 males (mean age 54.1±11.5 years) with terminal heart failure before and 3 months after implantation of an LVAD. The group consisted of 3 patients with dilated cardiomyopathy, 3 patients with ischemic cardiomyopathy, 1 patient with both conditions and 1 patient with congenital valvular disease. The concentration of endothelial microparticles was determined by ELISA Zymutest MP activity test. RESULTS: We did not observe a significant change in the concentration of circulating endothelial microparticles measured before and 3 months after implantation (p=0.669). High inter-individual variability in response to implantation was found. However, no association between a change in endothelial microparticle concentration and heart failure aetiology or a significant clinical complication attributed to LVAD implantation was observed. CONCLUSION: Results from this preliminary pilot study do not indicate that LVADs contribute to short-term vascular damage as defined by an increase in circulating endothelial microparticles.

KW - Circulating endothelial microparticles

KW - Endothelial dysfunction

KW - Heart failure

KW - Non-pulsatile flow

KW - Ventricle assist device

UR - http://www.scopus.com/inward/record.url?scp=84871076697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871076697&partnerID=8YFLogxK

M3 - Article

C2 - 23183513

AN - SCOPUS:84871076697

VL - 33

SP - 68

EP - 72

JO - Neuroendocrinology Letters

JF - Neuroendocrinology Letters

SN - 0172-780X

IS - SUPPL. 2

ER -